Anthony Sinskey Net Worth & Insider Trades
Anthony Sinskey - Director, Merrimack Pharmaceuticals Inc
What is Anthony Sinskey's Net Worth?
The current estimated net worth of Merrimack Pharmaceuticals Inc's Director, Anthony Sinskey, is estimated to be about $8.22M . Anthony Sinskey owns about 422,543 units of Merrimack Pharmaceuticals Inc common stock. In the last 2 years at Merrimack Pharmaceuticals Inc, Anthony Sinskey has sold an estimated value of $206.2K worth.
What is Anthony Sinskey's Past Insider Trading?
Anthony Sinskey's largest purchase order was 61,889 units , worth over $49.99K on April 5, 2012. Anthony Sinskey's largest sale order was 20,000 units , worth over $206.2K on December 22, 2014. In total, Anthony Sinskey has made about 9 transactions over 2 years of their time at Merrimack Pharmaceuticals Inc. Anthony Sinskey usually trades in August, with the busiest year in 2014, 2013 and 2012.
Anthony Sinskey
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Anthony Sinskey's' Mailing Address?
- Mailing address is C/o Metabolix 21 Erie Street Cambridge MA 02139 MA
Merrimack Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Gary L. Crocker | 2019 | $76,000 | $ | $19,258 | $ | $ | $95,258 |
| Richard Peters | 2019 | $383,676 | $294,891 | $ | $ | $935,369 | $1,613,936 |
| Jean M. Franchi | 2019 | $214,087 | $77,544 | $ | $ | $524,461 | $816,092 |
| Jeffrey A. Munsie | 2019 | $209,658 | $72,015 | $ | $ | $478,659 | $760,332 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm
What are Merrimack Pharmaceuticals Inc's Past Insider Trades?
Merrimack Pharmaceuticals Inc's most recent insider trade came on March 22, 2023 by Eric Andersen, Western Standard Llc, Western Standard Partners Lp and Western Standard Partners QP Lp who bought 160,590 units worth $1.85M . In the last 11 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $27.66M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks, Michael Porter, Director, and Edward Stewart, Head Commercial .
MERRIMACK PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||